Alphaform

Alphaform Net Debt / EBITDA

The Net Debt to EBITDA of Alphaform (AFRMF) as of Oct 26, 2026 is 0.21.

Net Debt / EBITDA

0.21

Last updated:

Net Debt to EBITDA of Alphaform is 2014 0.21 . Net Debt to EBITDA of Alphaform was 2013 - . It decreases by % lower compared to the previous year.

The Alphaform Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2007
-15.27 EUR
Jan 1, 2008
5.02 EUR
Jan 1, 2009
0.73 EUR
Jan 1, 2010
-2.53 EUR
Jan 1, 2011
-0.62 EUR
Jan 1, 2012
0.99 EUR
Jan 1, 2013
-0.35 EUR
Jan 1, 2014
0.21 EUR
The Alphaform Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
0.21-160.05%
-0.35-134.98%
0.99-259.72%
-0.62-75.49%
-2.53-445.64%
0.73-85.44%
5.02-132.89%
-15.27-862.12%
2.00-84.19%
12.67+11.93%
11.32-24.10%
14.92+808.95%
1.64-69.38%
5.36-410.98%
-1.72—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alphaform Stock analysis

What does Alphaform do? Alphaform AG generates revenue through industrial development services and production using innovative 3D printing technologies. The company specializes in laser sintering and stereo-lithography, producing prototype parts and models from resin and plastic powder. Clients from the automobile and aerospace industries purchase these services, including modeling, finishing, coating, and metal coating. Subsidiaries like Alphaform-Claho GmbH provide additional services such as tool making and CNC milling, while Medi-Met Precision Casting and Implants Technology GmbH focuses on manufacturing semi-finished medical implants like knee and hip implants. Alphaform-Claho GmbH serves clients requiring precision tool making and CNC milling for various parts, complementing Alphaform AG's core 3D printing offerings. Medi-Met Precision Casting and Implants Technology GmbH targets the medical sector with semi-finished implants, directly serving healthcare providers and medical device manufacturers. The company’s product portfolio spans industrial prototyping, precision manufacturing, and medical implant components, all delivered through its subsidiaries and core services. The automobile and aerospace industries are key clients for Alphaform AG's 3D printed parts and related services. Alphaform-Claho GmbH supports these sectors with tool making and CNC milling capabilities, enhancing the production process for complex components. Medi-Met Precision Casting and Implants Technology GmbH caters to the medical industry, supplying semi-finished implants that require high precision and specialized manufacturing techniques. Alphaform is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alphaform stock

Net Debt to EBITDA of Alphaform is 0.21 in 2014.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Alphaform since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Alphaform with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Alphaform

All Key Metrics — Alphaform